1. Academic Validation
  2. Homeodomain protein PRRX1 anchors the Ku heterodimers at DNA double-strand breaks to promote nonhomologous end-joining

Homeodomain protein PRRX1 anchors the Ku heterodimers at DNA double-strand breaks to promote nonhomologous end-joining

  • Nucleic Acids Res. 2025 Mar 20;53(6):gkaf200. doi: 10.1093/nar/gkaf200.
Yan Wang 1 2 Fuyuan Shen 1 2 Chen Zhao 1 2 Jiali Li 1 2 Wen Wang 1 2 Yamu Li 3 Jia Gan 1 2 Haojian Zhang 2 Xuefeng Chen 2 Qiang Chen 2 Fangyu Wang 1 2 Ying Liu 1 2 Yan Zhou 1 2
Affiliations

Affiliations

  • 1 Department of Neurosurgery, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China.
  • 2 Frontier Science Center of Immunology and Metabolism, Wuhan University, Wuhan 430071, China.
  • 3 The First Affiliated Hospital of Henan University, Kaifeng 475004, China.
Abstract

The DNA-dependent protein kinase (DNA-PK) complex plays a critical role in nonhomologous end-joining (NHEJ), a template-independent pathway for repairing DNA double-strand breaks (DSBs). The association of Ku70/80 with DSB ends facilitates the assembly of the DNA-PK holoenzyme. However, key mechanisms underlying the attachment and stabilization of DNA-PK at broken DNA ends remain unclear. Here, we identify PRRX1, a homeodomain-containing protein, as a mediator of chromatin localization and subsequent activation of DNA-PK. PRRX1 oligomerizes to simultaneously bind to double-strand DNA and the SAP (SAF-A/B, Acinus, and PIAS) domain of Ku70, thereby enhancing Ku anchoring at DSBs and stabilizing DNA-PK for efficient NHEJ repair. Reduced expression or pathogenic mutations of PRRX1 are associated with genomic instability and impaired NHEJ repair. Furthermore, a peptide that disrupts PRRX1 oligomerization compromises NHEJ efficiency and reduces cell survival following irradiation. These findings provide new insights into the activation of the NHEJ machinery and offer potential strategies for optimizing Cancer therapies.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-117693
    99.22%, Mre11-Rad50-Nbs1 Complex Inhibitor